ersonal use only
Investor Briefing
H1 FY22
RESULTS
28 February 2022
Martin Perelman
Founder & MD
Ivan Jacques
CFO
SILK Group H1 FY22 results highlights
onlyuse ersonal2
$76.4m $40.5m $12.7m
Network cash sales | Revenue | Pro forma EBITDA | ||||||||
+70% vs PCP | +32% vs PCP | +20% vs PCP | ||||||||
$5.7m $4.1m +7%
Pro forma NPAT1 | Statutory NPAT | Like-for-like growth of | ||||||||
+2% vs PCP | network cash sales | |||||||||
H1 FY22 includes ASC/TCC from 1/9/21. Network cash sales adjusted for lost trading days.
Note1: Pro-forma NPAT net of Non Controlling Interest.
This slide is not referring like-for-like - refer to slide 8 for breakdown
Integration of ASC/TCC progressing as planned
onlyuse ersonal3
Skincare products
ASC's skincare distribution business now fully integrated
SILK's ARx premium range being introduced to ASC clinics
NZ regulatory approval being sought for SILK's Medipen device
Supporting the franchise network
SILK's franchisee support and sales culture is being introduced and has been well received
SILK daily dashboards being rolled out in ASC with positive response from franchisees
Operational efficiencies
Finance & HR support functions combined.
Investing $1.5m to $2.0m in an upgrade of HR, Finance and POS platforms in H2
Review of procurement tendering to harmonise injectable offerings and supplier pricing
Significant opportunities to leverage SILK's partnership with Allergan and introduce Coolsculpting to ASC/TCC
Injectables
Product offering, franchise margins, retail price points and packages being aligned
Medipen to be rolled out across ASC Network in H2 FY22
Strong bounceback in Q2 FY22
Q1 FY22 impacted by lost trading days as a result of COVID lockdowns. | |||||
only | Sales rebounded well in Q2 FY22 post opening and have returned to normal, consistent levels after a | ||||
6- 8 week bounce back. | |||||
Online training implemented during lockdowns to keep staff engaged and up-to-date with | |||||
best practices. | |||||
use | |||||
Weekly sales | |||||
ersonal | |||||
Weekly days traded | |||||
4 | |||||
"SILK helped us pull the business together so we could trade through the uncertainty, keep our staff engaged and ensure both our team and our customers were safe."
Nurse Cher , Prospect SA
onlyuseOperational strategy ersonaltranslating to
financial results
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Silk Laser Australia Ltd. published this content on 27 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 February 2022 22:11:10 UTC.